Cargando…
Skipping the Drip: Intravenous Proton Pump Inhibitor Bolus Therapy Leads to Poor Outcomes in High-Risk Bleeding
Background and Aim The aim of this study was to evaluate the impact of a change in our institute’s protocol from continuous intravenous (IV) proton pump inhibitor (PPI) therapy to bolus IV PPI therapy for the treatment of peptic ulcer-related bleeding on patient outcomes. Current guidelines recommen...
Autores principales: | Khan, Raja Samir, Hadi, Yousaf B, Chima, Noor, Kupec, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325381/ https://www.ncbi.nlm.nih.gov/pubmed/32617233 http://dx.doi.org/10.7759/cureus.8362 |
Ejemplares similares
-
Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2020) -
Serum concentration and safety of intravenous drip versus subcutaneous administration of carboplatin in dogs
por: IWANO, Masataka, et al.
Publicado: (2021) -
A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
por: Tang, Jevon, et al.
Publicado: (2021) -
“Get Me Off This Medication!”: A Comparison Between Gastroenterology and Primary Care Regarding Patient’s Perceptions of Proton Pump Inhibitor Therapy
por: Khan, Raja Samir, et al.
Publicado: (2020) -
Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021)